Literature DB >> 32016088

Are the long-term outcomes of percutaneous ablation for clinical stage T1 renal tumors similar to those of partial nephrectomy?

Roy Mano1,2, A Ari Hakimi2.   

Abstract

Entities:  

Year:  2019        PMID： 32016088      PMCID： PMC6976441          DOI： 10.21037/atm.2019.08.106

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  19 in total

1.  Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Antonio Finelli; Nofisat Ismaila; Bill Bro; Jeremy Durack; Scott Eggener; Andrew Evans; Inderbir Gill; David Graham; William Huang; Michael A S Jewett; Sheron Latcha; William Lowrance; Mitchell Rosner; Bobby Shayegan; R Houston Thompson; Robert Uzzo; Paul Russo
Journal:  J Clin Oncol       Date:  2017-01-17       Impact factor: 44.544

Review 2.  Ablative Therapies for the Treatment of Small Renal Masses: a Review of Different Modalities and Outcomes.

Authors:  Nicholas Kavoussi; Noah Canvasser; Jeffrey Caddedu
Journal:  Curr Urol Rep       Date:  2016-08       Impact factor: 3.092

Review 3.  Management of Renal Masses and Localized Renal Cancer: Systematic Review and Meta-Analysis.

Authors:  Phillip M Pierorazio; Michael H Johnson; Hiten D Patel; Stephen M Sozio; Ritu Sharma; Emmanuel Iyoha; Eric B Bass; Mohamad E Allaf
Journal:  J Urol       Date:  2016-05-06       Impact factor: 7.450

4.  Renal Mass and Localized Renal Cancer: AUA Guideline.

Authors:  Steven Campbell; Robert G Uzzo; Mohamad E Allaf; Eric B Bass; Jeffrey A Cadeddu; Anthony Chang; Peter E Clark; Brian J Davis; Ithaar H Derweesh; Leo Giambarresi; Debra A Gervais; Susie L Hu; Brian R Lane; Bradley C Leibovich; Philip M Pierorazio
Journal:  J Urol       Date:  2017-05-04       Impact factor: 7.450

5.  Evolving Trends for Selected Treatments of T1a Renal Cell Carcinoma.

Authors:  Johnathan Doolittle; Joshua Piotrowski; Keegan Zuk; Kenneth Jacobsohn; Peter Langenstroer; William See; Scott Johnson
Journal:  Urology       Date:  2019-07-04       Impact factor: 2.649

6.  Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.

Authors:  Ephrem O Olweny; Samuel K Park; Yung K Tan; Sara L Best; Clayton Trimmer; Jeffrey A Cadeddu
Journal:  Eur Urol       Date:  2012-01-10       Impact factor: 20.096

7.  Management of Small Kidney Cancers in the New Millennium: Contemporary Trends and Outcomes in a Population-Based Cohort.

Authors:  William C Huang; Coral L Atoria; Marc Bjurlin; Laura C Pinheiro; Paul Russo; William T Lowrance; Elena B Elkin
Journal:  JAMA Surg       Date:  2015-07       Impact factor: 14.766

8.  R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience.

Authors:  Juan C Camacho; Nima Kokabi; Minzhi Xing; Viraj A Master; John G Pattaras; Pardeep K Mittal; Hyun S Kim
Journal:  J Vasc Interv Radiol       Date:  2015-03-11       Impact factor: 3.464

9.  Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.

Authors:  Peter A Caputo; Homayoun Zargar; Daniel Ramirez; Hiury S Andrade; Oktay Akca; Tianming Gao; Jihad H Kaouk
Journal:  Eur Urol       Date:  2016-08-25       Impact factor: 20.096

Review 10.  Partial Nephrectomy versus Thermal Ablation for Clinical Stage T1 Renal Masses: Systematic Review and Meta-Analysis of More than 3,900 Patients.

Authors:  J Ricardo Rivero; Jose De La Cerda; Hanzhang Wang; Michael A Liss; Ann M Farrell; Ronald Rodriguez; Rajeev Suri; Dharam Kaushik
Journal:  J Vasc Interv Radiol       Date:  2018-01       Impact factor: 3.464
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.